Fouad Brahimi

An Agonistic TrkB mAb Causes Sustained TrkB Activation, Delays RGC Death, and Protects the Retinal Structure in Optic Nerve Axotomy and in Glaucoma

Yujing Bai, Jing Xu, Fouad Brahimi et al. · Investigative Ophthalmology & Visual Science · 2010 · 87 citations

Medicine, Neuroscience, Pharmacology +17

The Combi-Targeting Concept:  Synthesis of Stable Nitrosoureas Designed to Inhibit the Epidermal Growth Factor Receptor (EGFR)

Juozas Domarkas, Fabienne Dudouit, Christopher Williams et al. · Journal of Medicinal Chemistry · 2006 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Bivalent Peptidomimetic Ligands of TrkC Are Biased Agonists and Selectively Induce Neuritogenesis or Potentiate Neurotrophin-3 Trophic Signals

Dianjun Chen, Fouad Brahimi, Yu Angell et al. · ACS Chemical Biology · 2009 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17

Inhibition of Epidermal Growth Factor Receptor-Mediated Signaling by “Combi-Triazene” BJ2000, a New Probe for Combi-Targeting Postulates

Fouad Brahimi, Stephanie L. Matheson, Fabienne Dudouit et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 50 citations

Medicine, Oncology, Pharmacology +14

Novel Nitrogen Mustard-Armed Combi-Molecules for the Selective Targeting of Epidermal Growth Factor Receptor Overexperessing Solid Tumors:  Discovery of an Unusual Structure−Activity Relationship

Zakaria Rachid, Fouad Brahimi, Qiyu Qiu et al. · Journal of Medicinal Chemistry · 2007 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17